Replies to post #9520 on Momenta Pharmaceuticals, Inc. (MNTA)

[linhdtu]

Yep I would agree with your understanding of the implication of today's ruling.

[DewDiligence]

If manufacturing patents pertaining to FDA-approved drugs are not going to be protected, MNTA will have to rely more on trade secrets.

In no way is today's ruling a possible "death blow" for the company, IMO. Several other companies working on FoB's are in the same boat.